Ester Falconer - 09 Jun 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Technology Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
09 Jun 2021
Net transactions value
-$25,500,000
Form type
4
Filing time
10 Jun 2021, 17:00:54 UTC
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Sale $25,500,000 -1,000,000 -100% $25.50 0 09 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.